← Upcoming Courses

Empagliflozin in Cardio-Renal Metabolic (CRM) Management

The "Empagliflozin in Cardio-Renal Metabolic (CRM) Management" course offers a comprehensive exploration of the evolving role of Empagliflozin in the management of cardio-renal metabolic conditions. This course places a special emphasis on the landmark EMPA Kidney Study, a pivotal clinical trial that has far-reaching implications for a broad population of patients with chronic kidney disease (CKD) beyond its initial application in glucose control. By delving into the intricate interplay of cardio-renal-metabolic systems, participants will deepen their understanding of how cardiovascular, renal, and metabolic diseases mutually influence one another. Upon completion of this course, participants will be able to:

1. Heart Failure Updates as discussed during the ESC Conference 2023:

    • Understand the latest developments and findings presented at the European Society of Cardiology (ESC) Conference in 2023 related to heart failure and its implications in cardio-renal metabolic management.

2. Role of Empagliflozin in CKD beyond T2DM:

    • Examine the extended applications of Empagliflozin in the treatment of chronic kidney disease (CKD) beyond its initial usage for type 2 diabetes mellitus (T2DM).

3. Cardio-renal metabolic benefits of Empagliflozin:

    • Analyze the comprehensive cardio-renal metabolic benefits of Empagliflozin, including its effects on cardiovascular health, renal function, and metabolic parameters in various patient populations.

 

Target Audience: Specialists, Family Physicians, General Practitioners, and Physician Assistants

Moderator: Dr. Karen Rotuk – Senior Medical Science Liaison – Boehringer Ingelheim

Time: 1600 GMT (4:00 pm local time)

 

AGENDA

Tuesday the 24th of October 2023 (VIRTUAL EVENT) 

3:50 - 4:00 pm: Welcome

4:00 - 4:05 pm: Meeting Opening - Faculty Introductions and Scientific Agenda by Dr. Karen Rotuk

4:05 - 4:35 pm: EMPA KIDNEY: Evolving Role of Empagliflozin in CKD  beyond glucose control by Dr. Yacoba Atiase.

4:35 - 4:50 pm: Case Discussion - T2D patient with low albuminuria diagnosed with CKD by Dr. Yacoba Atiase.

4:50 - 5:05 pm: ESC 2023 Heart Failure Focused Updates-  Breaking barriers in HFpEF Management by Dr. Francis Agyekum

4:55 - 5:10 pm: Case Discussion - Patient newly diagnosed with HFpEF by Dr. Francis Agyekum

5:10 - 5:40 pm: Question and Answer Session Dr. Yacoba Atiase and Dr. Francis Agyekum

5:40 - 5:55 pm: 5 Key Takeaways and Closing - All

  

PROUDLY SPONSORED BY

 

 

This is a virtual event that will take place on Tuesday the 24th of October 2023 at 4:00 pm. The event will be streamed live on this page.

Overview

Course Description

This virtual training aims to equip participants with a deep understanding of the connections between cardiovascular, renal, and metabolic conditions, and how Empagliflozin plays a pivotal role in managing these intertwined aspects of health. Participants will gain insights that can significantly impact their clinical practice and improve patient care.

What you will learn

Upon completion of this course, participants will be able to:

1. Understand Heart Failure Updates as discussed during the ESC Conference 2023

2. Appreciate and understand the role of Empagliflozin in CKD beyond T2DM

3. Appreciate and understand the Cardio-Renal Metabolic benefits of Empagliflozin

Course Content


Lecture Sessions

  • LIVE EVENT: Tuesday 24th October 2023 @ 1600 GMT (4:00 pm) 1 hour 30 minutes

Downloadables

No downloadable content added to this course yet.

About Facilitators

  • 1 Course on CES

Dr Yacoba Atiase

FWACP, MAACE, MSc, PGDip, Endo. MBChB, BSc, Cert. HAM

Senior Lecturer, Consultant Physician, Diabetologist, and Endocrinologist

Director – National Diabetes Management and Research Centre (NDMRC)

r Yakoba Atiase is the Director of the National Diabetes Management and Research Centre (NDMRC). She is also a Senior Lecturer at the University of Ghana Medical School.

View full profile / courses

  • 1 Course on CES

Dr Francis Agyekum

MBChB, FGCP, FWACP (Int. Med – Cardiol), Cert (Interv. Cardiol)

Interventional Cardiologist and Lecturer.

Korle-Bu Teaching Hospital, and the , School Of Medicine & Dentistry, College Of Health Sciences, University Of Ghana, Legon.

Dr. Francis Agyekum is a lecturer with the University of Ghana Medical School, College of Health Sciences, Legon. He is also a Consultant Cardiologist at the Korle-Bu Teaching Hospital. Dr.

View full profile / courses